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Purpose: To develop an ibuprofen transdermal gel with a capability for both topical and systemic drug 
delivery. 
Methods: Ibuprofen gel formulations, incorporating various permeation enhancers, were prepared using 
chitosan as a gelling agent. The formulations were examined for their in vitro characteristics including 
viscosity, pH and drug release as well as in vivo pharmacological activities. Carrageenan-induced rat 
paw oedema model was used for the evaluation of their analgesic and anti-inflammatory activities. A 
commercial ibuprofen gel product (Ibutop
®
) was used as a reference. 
Results: The formulations containing 5 % of either menthol or glycerol as permeation enhancers gave 
drug release patterns comparable to that of the reference product. Propanol increased the apparent 
viscosity of the test gels to the same extent as that of the reference. Drug release from the formulations 
fitted best to the Higuchi model. A significant in vivo analgesic effect was produced by the test 
formulations containing 5 % menthol and 20 % propylene glycol and the effect was superior to that 
obtained with the reference product. However, no significant anti-inflammatory activity was exerted by 
any of the test gel formulations (p > 0.05). 
Conclusion: Ibuprofen gel preparations containing 5 % menthol and 20 % propylene glycol, 
respectively, exhibited pronounced analgesic activity and could be further developed for topical and 
systemic delivery of ibuprofen. 
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Drug delivery through the skin has been a 
promising concept for a long time because 
skin is easy to access, has a large surface 
area with vast exposure to the circulatory and 
lymphatic networks and the route is non-
invasive. [1]. Transdermal delivery is of great 
importance for drugs that may cause 
systemic side effects such as non steroidal 
anti-inflammatory drugs (NSAIDs)[2]. 
 
Ibuprofen is an effective non-steroidal anti-
inflammatory drug (NSAID) often used in the 
treatment of acute and chronic arthritic 
conditions [3]. There is great interest to 
develop non-oral dosage forms of ibuprofen 
to minimize its gastric side effects and to 
provide relatively consistent drug levels at the 
application site for prolonged periods [2]. 
Transdermal delivery of ibuprofen using 
various formulations has been described in 
the literature [4,5]. However, effective 
permeation of ibuprofen through skin is 
difficult to achieve due to its intrinsically poor 
permeability, though this is relatively good 
compared to other commonly used NSAIDs 
[6]. However, skin permeation enhancers 
could be used to improve drug skin 
penetration [7].  
 
Chitosan has unique non-toxic and 
antimicrobial characteristics, along with a 
solution property and other attributes which 
make it an attractive biopolymer for many 
pharmaceutical and biomedical applications 
via different routes of administration [8]. It has 
been is used in gel formulations to prolong 
drug residence time as well as reduce the 
application frequency and amount of drug 
administered, factors which might improve 
patient compliance and acceptance [9].  
 
Carrageenan-induced paw oedema in mice 
has been widely used for the evaluation of 
analgesic and anti-inflammatory activities of 
drugs since the relative potency found for 
most drugs tend to reflect clinical experience 
[10].   
The aim of this study was to develop suitable 
transdermal gel formulations of ibuprofen 
using chitosan polymer as a gelling agent, 






Ibuprofen was kindly provided by Gulf 
Pharmaceutical Industries, UAE while Ibutop
®
 
gel 5% was obtained from Deutsche Chefaro 
Pharma GmbH, Germany. Other materials 
used were chitosan (MW: 2.5 x103 kDa, 
Biotech. Co. Ltd Korea), a synthetic 
hydrophilic membrane (GH Polypro filter, 
Waters Corporation, Philadelphia, PA) with a 
pore size of 0.45 mm, menthol (Pacegrone, 
England), glycerol (E. Merck, Germany), 
propanol (ADWIC, Egypt), oleic acid (AIMIA, 
Australia), propylene glycol (Fluka Chemie, 
Switzerland), polyethylene glycol PEG400 
(Sigma, Germany), potassium dihydrogen 
phosphate (E. Merck, Germany), di-sodium 
hydrogen phosphate (Qualikems Fine 
Chemicals, India), sodium acetate (Scharlau 
Chemie, Spain), and carrageenan κ (Sigma- 
Aldrich, USA). All organic solvents used were 
of high-performance liquid chromatography 
(HPLC) grade.  
 
Preparation of Ibuprofen Gel 
 
Chitosan gel was prepared by dissolving 1 g 
of chitosan powder in 0.1M sodium acetate 
buffer (pH 4.5), to give a final concentration 
of 5 %w/w, with continuous mixing using a 
magnetic stirrer until a homogenous gel was 
formed. The gel was set aside for few 
minutes until the bubbles disappeared. 
Ibuprofen (0.05 g) was mixed with propanol 
to a level of 5 %w/w and incorporated into the 
gel. Six different formulations (F1 – F6) were 
prepared (in addition to the blank and 
reference product) by incorporating different 
permeation enhancers to the final gel, as 
shown in Table 1. The gels were kept in 
plastic well-closed containers and stored at 
room temperature until the time of analysis. 
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Determination of gel viscosity 
 
The viscosity of the formulations and 
reference was performed using a Brookfield 
digital viscometer (Model DV-II, USA) 
equipped with spindle S27. The apparent 
viscosity was measured at 17 seconds
−1
 
shear rate (50 rpm) and room temperature, 
after a 3-min rest time [11].       
 
Determination of gel pH 
 
One gram each of the gel formulations and 
the reference was accurately weighed and 
dispersed in 10 ml of purified water. The pH 
of the dispersions was measured with a pH 
meter (Hanna Instruments, HI8417, Portugal) 
[12] . 
 
Evaluation of in vitro ibuprofen release  
 
A synthetic hydrophilic membrane was 
mounted on a Franz diffusion cell 
(PermeGear, Riegelsville, PA, USA). The 
receptor compartment contained 6.5 mL of 
phosphate buffer (pH 7.4). One gram of the 
test formulation or reference was applied to 
the membrane over an area of 1.131 cm
2
 
area across the donor compartment. The 
donor cell was exposed to ambient 
temperature and covered with parafilm to 
prevent evaporation. The temperature of the 
receptor compartment was maintained at 32 
ºC while the buffer solution was stirred 
continuously with a Teflon-coated magnetic 
bar. Samples (0.5 ml) were withdrawn from 
the release medium at 0, 0.5, 1, 1.5, 2, 3, 4, 
6, and 8 h and replaced with an equal volume 
of fresh buffer solution to maintain sink 
conditions. The samples were analyzed by 
high performance liquid chromatography 
(HPLC) using the operating parameters 
described below (see ‘HPLC analysis’). 
 
Cumulative amount of the drug permeated 
versus time (Zero order) and also versus 
square root of time (Higuchi model, Eq. 1 ) 
were obtained [13]. 







=   ……….….……..  (1) 
where C° = initial drug concentration in the 
donor compartment; Q = cumulative amount 





Analysis of ibuprofen in samples was 
performed using a Waters HPLC system 
equipped with a 1515 pump, 2487 detector, 
717 P auto-samplers and C18 column (5.0 
µm, 3.9 mm x 150 mm). The mobile phase 
used was a mixture of 0.01M H3PO4 and 
acetonitrile (55: 45). The flow rate was 
adjusted to 1ml/min and the injection volume 
was 20 µL. The ultraviolet (UV) detector was 
set at a wavelength of 264 nm [14] and the 
retention time was 7.129 min. 
 
Conditioning of the animals  
 
The experiments were conducted using 
female albino mice weighing 32 - 34 g, taken 
from the Central Animal House, Dubai 
Pharmacy College, UAE. The animals were 
kept in plastic cages with soft bedding (6 per 





























































































F1 0.05 1.0 - - - - - - 




F3 0.05 1.0 5.0 
2
0 
- - - - 
F4 0.05 1.0 5.0 - - - - 
5.
0 
F5 0.05 1.0 5.0 - 3.0 - - - 
F6 0.05 1.0 5.0 - - 1.0 - - 




- - - - - - - - 
Rasool et al 
Trop J Pharm Res, August 2010; 9 (4): 358 
cage) under standard conditions of light and 
dark cycle and had free access to food and 
tap water. They were allowed to acclimatize 
for one week before the experiments. Ethical 
approval was given for the animal skin 
studies by the Research Ethics Committee of 
Dubai Pharmacy College and animal 
experiments were conducted in accordance 
with the “Guide for the Care and Use of 
Laboratory Animals” (NIH Publication no. 85-
23) [15]. 
 
Skin irritation test 
 
This test was performed in accordance with 
ASTM method F719 – 81 [16]. A group of 
three male albino rabbits weighing 
approximately 1 kg were used in the test. The 
ventral side of the animal was carefully 
shaved, and six circular areas of 2.5 cm in 
diameter were drawn on the animal's 
abdomen. The circumscribed areas were 
painted with 20 % aqueous solution of 
formaldehyde. for lipid drying and the solution 
was allowed to evaporate. Approximately 0.5 
g of the formulations F1, F2, F3, F4 and 
ibuprofen powder were placed on five of the 
circular areas and a substance of known 
irritancy (histamine) was injected 
intradermally into the sixth circular area for 
the purpose of calibration. The back of the 
animal's ear was shaved carefully; a piece of 
cotton was immersed in a small amount of 
xylene and applied to the shaved portion in 
order to dilate the superficial ear vein. One 
millilitre of 0.5 % trypan blue was slowly 
injected into the selected vein and the degree 
of the resulting irritancy was estimated by the 
level of accumulation of trypan blue at the 
treated site. The degree of blueness was 
visually ranked to provide a relative order of 
irritancy of the substance used. The 
observations were made after 1, 6 and 24 h.  
 
Evaluation of carrageenan-induced paw 
oedema 
 
Animals were divided into eight groups with 
eight animals in each; the first three groups 
served as controls: (a) un-inflamed, injected 
with saline; (b) inflamed, injected with 
carrageenan; (c) inflamed, treated with the 
reference product. The other five groups 
were inflamed and treated with the test 
ibuprofen formulations F1, F2, F3 and F4, 
and blank. Carrageenan solution (1 %w/v, in 
normal saline) was used to induce 
inflammation. The animals were placed singly 
in observation chambers for 10 min to 
minimize any stress-related behavioral 
changes. The mice then received sub-plantar 
administration of 50 µl of the carrageenan 
solution in the left hind paw and were 
returned immediately to the observation 
chamber. The thickness (mm) of the paw was 
measured at 0, 1, 2, 3 and 4 h after 
carrageenan administration, using an 
electronic digital caliper (Traceable Calipers, 
Friendswood, TX, USA) [17].  
 
The gel formulations or the reference were 
applied to the plantar surface of the left hind 
paw by gently rubbing 0.5 g of the formulation 
50 times with the index finger. Thirty minutes 
later, pleurisy was induced by injecting 50 µl 
of 1% w/v carrageenan solution subcuta-
neously into the sub-plantar surface of the left 
paw of the mice. Control un-inflamed animals 
received 50 µl normal saline subcutaneously 
into the sub-plantar surface of the left paw 
[18].   
 
Determination of analgesic activity  
 
Mice were divided into eight groups with eight 
animals per each and the test was carried out 
by the hot plate method [18]. The animals 
were habituated twice to the hot-plate in 
advance. The first three groups served as 
controls: (a) un-inflamed, injected with saline; 
(b) inflamed, injected with carrageenan; (c) 
inflamed, treated with the reference product. 
The other five groups were inflamed and 
treated with the test ibuprofen formulations 
F1, F2, F3 and F4, and blank. Thirty minutes 
prior to treatment, 1 % carrageenan 
suspension (0.01 ml) was injected into the 
subplanter area of the right hind paw  In the 
test, the mice were placed on a hot plate 
maintained at 55 ± 0.5 
0
C. The time elapsed 
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until the occurrence of either a hind paw 
licking or a jump off the surface was recorded 
as the hot-plate latency. The animals were 
tested at 0 (baseline), 0.5, 1.0, 1.5, 2.0, 2.5 
and 3.0 h. The cut-off time was 22.5 s to 
prevent tissue damage and mice with 
baseline latencies of < 5 were eliminated 
from the study.    
 
Data analysis 
The results were expressed as mean ± 
standard deviation. Analysis of variance 
(ANOVA) was performed for multiple 
comparisons followed by Bonferroni's multiple 
comparison. A level of significance of p < 
0.05 was set to determine any significant 





Viscosity of gel formulations 
 
The results showed that there was no 
significant difference (p < 0.05) between the 
viscosities of gel formulations F2 - F6 and 
that of the reference. The addition of 
propanol produced a significant increment in 
the apparent viscosity of the prepared gels, 
compared with F1 (p < 0.05), as shown in 
Table 2. 
 
Table 2: Viscosity, release rate constant and 
correlation coefficient (r
2
) of the formulation 
 
In vitro drug release 
 
Ibuprofen release profiles over time from the 
various formulations and the reference are 
shown in Fig 1. The regression data for two 
kinetic models - zero order and Higuchi -  
indicate that the data fitted better to the 
Higuchi model as indicated by higher r
2 
values. The plot of the cumulative ibuprofen 
permeation through the synthetic membrane 
versus square root of time (not shown) was 
linear, thus indicating matrix diffusion-
controlled release kinetics. The drug release 
rate constants of the test formulations are 
presented in Table 2.  
 
 
Figure 1: In vitro drug release profiles of (A) gel 
formulations F1 (○), F2 (□), F3 (∆) and Ibutop (♦); 
and (B) gel formulations F4 (○), F5 (□), F6 (∆) and 
Ibutop (♦). 
 
The release rate constants of ibuprofen from 
the various formulations follow the rank order: 
F4 > F2 > F3 > F1 > F5 > F6, thus indicating 
that incorporation of menthol, glycerol and 
propylene glycol significantly (p < 0.05) 
increased drug release rate constants. In 
contrast,, drug release rate constant was not 
affected by the incorporation of either oleic 
acid nor PEG 400 (p > 0.05). There was, 
however, no significant difference (p > 0.05) 




Ibuprofen–chitosan gel formulations were 
yellow in colour, homogeneous in texture and 
fell within a pH range of 4.5 to 5.0 which is 
compatible with normal skin pH in healthy 
people [19]. The results showed that after 










F1 67700± 100 58.65 ± 1.88 0.99 
F2 72200±122 83.50 ± 2.38 0.99 
F3 72320± 120 61.76 ± 1.98 0.99 
F4 72355±111 86.00 ± 3.45 0.99 
F5 71900 ± 100 45.94 ± 3.42 0.96 
F6 72860 ± 125 44.22 ± 3.69 0.95 
Blank - - - 
Ibutop® 72500 ± 123 91.72 ± 4.00 0.99 
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site became gradually blue with the maximum 
intensity of blueness occurring after 6 h. The 
intensity of blueness at the histamine site 
served as reference to other sites. The 
intensity of blueness increased only at the 
histamine site only, and hence the test gels 




The results (mice paw size) of the anti-
inflammatory test are shown in Fig 2. There 
was no significant difference between the 
anti-inflammatory effects of the test 
formulations and the reference and also the 
inflamed group (p>0.05) over the duration of 
the test.  
 
 
Figure 2: Anti-inflammatory effect of the test 
formulations, reference and control in 
carrageenan-induced paw oedema in mice (Error 
bar represents standard deviation)  
 
Analgesic effect  
 
The results of the assessment of analgesic 
activity are shown in Fig 3. Formulation F4 
(containing menthol as permeation enhancer) 
showed a higher analgesic effect than the 
reference (p < 0.01). F3 formulation, with 
propylene glycol as permeation enhancer, 
also exhibited a significantly greater 
analgesic effect than the reference product (p 
< 0.05). F1 and F2 did not show significant 
analgesic effect (p > 0.05).  Chitosan, which 
was the gel polymer used (represented by 
blank), did not show significant analgesic or 
anti-inflammatory activities (p > 0.05).  
 
 
Figure 3: The analgesic effect on mice (measured 
by latency) of the different formulations using the 
hot plate method. (** P < 0.01, *P < 0.05; error bar 
represents standard deviation) 
 
The analgesic effect of the preparations in 
relation to time is illustrated in Fig 4. Saline 
injection had no effect on paw withdrawal 
latencies (PWLs). A high significant (p < 0.01) 
reduction in PWLs compared to that of the 
reference was observed immediately after the 
application of formulation F4 which persisted 
for 2.5 h. Similarly, a significant decrease in 
PWLs occurred followed application of 
formulation F3 but this was after a lag of 1 h 




Figure 4: Effect of selected formulations on time 
course of carrageenan-induced hyperalgesia in 
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DISCUSSION 
 
The aim of the study is to develop ibuprofen 
transdermal gel formulations using various 
permeation enhancers and chitosan as 




The apparent viscosity of the test 
formulations was comparable to that of the 
reference standard, Ibutop
®
. However, the 
inclusion of propanol increased the apparent 
viscosity of the test gels. This effect of 
propanol may be due to the association of the 
hydrophobic parts of the polymer (chitosan) 
with the alcohol, thus minimizing hydrophobic 
contact with water. The polymer–alcohol 
complex probably became more hydrophilic, 
thus making water a better solvent for the 
polymer. This complex might have expanded 
more in water and hence the increase in 




In vitro drug release data from the test 
formulations fitted better to the Higuchi model 
than to the zero order model, an indication 
that the former more suitably described 
ibuprofen release kinetics from the test 
formulations and that drug release was 
matrix-diffusion controlled. The use of 
menthol, glycerol and propylene glycol (PG) 
as permeation enhancers significantly 
increased drug release rate constants 
compared to F1 which had no permeation 
enhancer. It has previously been shown that 
ibuprofen solubility is enhanced by the 
addition of menthol, due probably to the 
formation of a eutectic mixture of ibuprofen 
and menthol in aqueous solution [21]. On the 
other hand, glycerol and PG enhanced drug 
solubility by co-solvency effect [22].  
 
It is generally agreed that in vitro drug 
release data for transdermal formulations 
cannot be used to accurately predict 
permeation across the skin, due to the barrier 
properties of the stratum corneum which can 
be altered by the composition of vehicle or 
the presence of various permeation 
enhancers in the formulation [23]. 
 
Anti-inflammatory and analgesic 
properties of the gel formulations 
 
The results showed that no significant anti-
inflammatory effect was shown either by the 
test formulations or the standard reference, 
Ibutop
®
. It may be that higher ibuprofen 
doses are required to produce in vivo anti-
inflammatory activity [24]. 
 
On the other hand, F4, which contained 
menthol as permeation enhancer, showed a 
higher analgesic effect than that of the 
reference standard. Some studies have 
reported that menthol is capable of acting as 
a skin penetration enhancer for a number of 
NSAIDs via different mechanisms such as 
induction of lipid packing disruption and 
formation of eutectic mixtures [25]. In addition 
to its well-known cooling effect via stimulation 
of skin's cold receptors [26], it also stimulates 
an axon reflex with subsequent release of 
vasodilator peptides [27] which may explain 
the high analgesic effect of the test 
formulation containing menthol.  
  
Formulation F3 (with propylene glycol as 
permeation enhancer) also exhibited a higher 
analgesic activity than the reference. This 
could be explained by the fact that propylene 
glycol (PG) can penetrate the stratum 
corneum in a manner proportional to its level 
in the applied formulation and appears to 
alter ibuprofen solubility in the barrier [28]. 
Moreover, PG possibly infiltrates the 
outermost layer of the intercellular spaces of 
the stratum corneum and because most of 
the water accumulates within the 
corneocytes, it seems likely that  PG 
withdraws water from the cells due to its 
hygroscopic nature, causing skin hydration 
and thus enhances drug penetration [24].  
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CONCLUSION 
 
New transdermal ibuprofen-chitosan gel 
formulations were developed successfully 
using different permeation enhancers and 
also propanol as a viscosity enhancing agent. 
Formulations containing 5% menthol and 
20% propylene glycol demonstrated superior 
analgesic effect to the reference product, 
Ibutop
®
 in mice. However, the formulations 
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